News

FDA Approves LITFULO™ (Ritlecitinib) for Adults and Children ages 12+ with Severe Alopecia Areata

Today, the U.S. Food and Drug Administration (FDA) approved LITFULO™ for severe alopecia areata, marking the second FDA-approved treatment for…

NAAF Community Member Gets Special Surprise on “The Today Show”

Isoken Igbinedion, Ifueko Igbinedion and Simone Kendle, the founders of Parfait Wigs – a NAAF Conference vendor – appeared on…

New Clinical Trial Data Published for Ritlecitinib

Results from a clinical trial for a new treatment for alopecia areata were published in the medical journal The Lancet…

NAAF Adds Two New Board Members

Shamsha Damani is a seasoned healthcare professional with a strong track record of driving business growth. With over 20 years…

NAAF Logo Green

NAAF Statement on the Upcoming Oscars

Alopecia areata is no joke. The controversy at the 2022 Academy Awards ceremonies helped raise important awareness of alopecia areata,…